We are live on
!
Find out more
IIM
INTECH Investment Management Portfolio holdings
AUM
$10.2B
1-Year Est. Return
28.14%
This Fund
S&P 500
This Quarter
Est. Return
-4.74%
1 Year Est. Return
+28.14%
3 Year Est. Return
+94.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$9.7B
AUM Growth
-$615M
(-6%)
Cap. Flow
+$46.7M
Cap. Flow
% of AUM
0.48%
Top 10 Holdings %
Top 10 Hldgs %
23.8%
Holding
2,583
New
206
Increased
1,731
Reduced
552
Closed
62
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$68.5M |
| 2 |
Merck
MRK
|
+$58.7M |
| 3 |
SMDX
Intech S&P Small-Mid Cap Diversified Alpha ETF
SMDX
|
+$53.4M |
| 4 |
Tesla
TSLA
|
+$51.6M |
| 5 |
Broadcom
AVGO
|
+$49.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$50.7M |
| 2 |
Progressive
PGR
|
+$46M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$41.3M |
| 4 |
Cintas
CTAS
|
+$40.1M |
| 5 |
Constellation Energy
CEG
|
+$36.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.32% |
| 2 | Financials | 14.34% |
| 3 | Healthcare | 13.01% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
ALX Oncology
ALXO
$290M
| $20K | ﹤0.01% |
32,106
+18,908
| +143% | +$22.7K |
|
2502
Actinium Pharmaceuticals
ATNM
$24.3M
| $19.9K | ﹤0.01% |
12,336
-1,862
| -13% | -$2.36K |
|
2503
FibroBiologics
FBLG
$6.5M
| $19.8K | ﹤0.01% |
1,100
+467
| +74% | +$13.3K |
|
|
RAPT
2504
DELISTED
RAPT Therapeutics
RAPT
| $19.2K | ﹤0.01% |
1,971
+127
| +7% | +$1.25K |
|
|
MODV
2505
DELISTED
ModivCare
MODV
| $18.9K | ﹤0.01% |
+14,367
| New | +$69.5K |
|
|
BOLD
2506
Boundless Bio
BOLD
$65.2M
| $17.8K | ﹤0.01% |
+11,809
| New | +$24.5K |
|
2507
Galectin Therapeutics
GALT
$318M
| $17.3K | ﹤0.01% |
+14,156
| New | +$19.9K |
|
2508
Century Therapeutics
IPSC
$359M
| $17K | ﹤0.01% |
35,814
+12,922
| +56% | +$9.71K |
|
2509
Solarmax Technology
SMXT
$21.2M
| $16.8K | ﹤0.01% |
+13,967
| New | +$20K |
|
2510
Tevogen Inc. Common Stock
TVGN
$26.4M
| $16.7K | ﹤0.01% |
310
+87
| +39% | +$5.72K |
|
|
GBIO
2511
DELISTED
Generation Bio
GBIO
| $15.4K | ﹤0.01% |
3,795
+1,461
| +63% | +$10.3K |
|
2512
Ovid Therapeutics
OVID
$478M
| $13.7K | ﹤0.01% |
44,010
+20,286
| +86% | +$12.5K |
|
2513
X4 Pharmaceuticals
XFOR
$442M
| $13.7K | ﹤0.01% |
+1,932
| New | +$26.6K |
|
2514
Outlook Therapeutics
OTLK
$202M
| $13K | ﹤0.01% |
+10,663
| New | +$18.7K |
|
|
IGMS
2515
DELISTED
IGM Biosciences
IGMS
| $12.7K | ﹤0.01% |
+11,069
| New | +$20.6K |
|
2516
374Water
SCWO
$37.4M
| $7.74K | ﹤0.01% |
+2,277
| New | +$10.1K |
|
2517
Verrica Pharmaceuticals
VRCA
$90M
| $6.91K | ﹤0.01% |
+1,562
| New | +$10.1K |
|
|
ELEV
2518
DELISTED
Elevation Oncology
ELEV
| $5.04K | ﹤0.01% |
+19,458
| New | +$11.1K |
|
|
SBDS
2519
DELISTED
Solo Brands Inc
SBDS
| $3.88K | ﹤0.01% |
579
+240
| +71% | +$7.35K |
|
2520
Solidion Technology
STI
$75.4M
| $2.1K | ﹤0.01% |
+348
| New | +$6.04K |
|
|
LYRA
2521
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $2.09K | ﹤0.01% |
+331
| New | +$3.1K |
|
|
AEVA
2522
Aeva Technologies
AEVA
$1.69B
| – | – |
-10,934
| Closed | -$51.9K |
|
2523
AGNC Investment
AGNC
$12.7B
| – | – |
-12,416
| Closed | -$114K |
|
2524
AppFolio
APPF
$7.06B
| – | – |
-15,629
| Closed | -$3.86M |
|
2525
Arrow Electronics
ARW
$10.4B
| – | – |
-3,632
| Closed | -$411K |
|
Similar funds
ACA
GI
VPIM
RA
RI
HRCM
WAM
HI
INTECH Investment Management's Q1 2025 Portfolio in Review
As of Q1 2025, INTECH Investment Management held 2,583 positions worth $9.7B, down 6% from $10.3B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
INTECH Investment Management's Q1 2025 filing shows 206 new, 1,731 increased, 552 reduced and 62 closed positions. Its largest new stake was Intech S&P Small-Mid Cap Diversified Alpha ETF: 2,762,981 shares worth $53.5M. The largest sale was Eli Lilly, an estimated $50.7M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Financials and Healthcare.
- INTECH Investment Management's largest Q1 2025 buy was Intech S&P Small-Mid Cap Diversified Alpha ETF: 2,762,981 shares worth $53.5M.
- INTECH Investment Management added most to Amazon in Q1 2025, an estimated $68.5M increase.
- INTECH Investment Management's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $50.7M.
- INTECH Investment Management fully exited Teleflex in Q1 2025, selling an estimated $7.45M.
- INTECH Investment Management's ten largest holdings make up 24% of its $9.7B portfolio in Q1 2025.
- INTECH Investment Management opened 206 new positions and closed 62 in Q1 2025.
- INTECH Investment Management's portfolio value fell 6% quarter-over-quarter to $9.7B.
Based on INTECH Investment Management's 13F filing for Q1 2025, filed 20 May 2025.